Tag Archives: Five Prime

November, 2017

October, 2015

May, 2015

  • 27 May

    Bluebird Bio Enters CAR T Deal with Five Prime

    Bluebird bio announced that it has entered into an immuno-oncology deal with Five Prime Therapeutics. The companies said that they have entered into an exclusive license agreement to research, develop and commercialize chimeric antigen receptor (CAR) T cell therapies. Under the agreement, the companies will use Five Prime’s proprietary human …